Abstract:
Described herein are aqueous organic redox flow batteries that include a first redox active material that can include a metallocene or a salt thereof, and a second redox active material that can include a viologen or a salt thereof. The aqueous organic redox flow batteries may further include a first aqueous electrolyte, a second aqueous electrolyte, and a separator between the first and second aqueous electrolytes. In addition, disclosed herein are methods of making the metallocene and viologen compounds.
Abstract:
A printed circuit board includes a mounting area. The mounting area includes a first mounting portion and a second mounting portion. The first and second mounting portions partially overlap. The first mounting portion includes a number of first holes, a number of second holes, and a third hole. The first holes, the second holes, and the third hole are configured for the mounting of signal pins of a universal serial bus (USB) pin. The second mounting portion includes the first holes and a number of fixing holes. The first holes are configured for the mounting of signal pins of a USB connector. The fixing holes are configured for the mounting of fixing pins of the USB connector.
Abstract:
A punching assembly includes a die base, a sleeve, an adjusting screw, a pull portion, a latching block, an elastic element, a fixing ring and a stop member. A top of the die base is received in the sleeve. The adjusting screw includes a contact end, a mounted end inserting into the sleeve and connecting to the top of the die base, and a latching portion located between the contact end and the mounted end. The pull portion is disposed around the sleeve. The latching block engages the latching portion. The elastic element is disposed around the adjusting screw, supporting the latching block. The fixing ring surrounding the adjusting screw is fixed on the sleeve. The stop member, contiguous with the fixing ring, prevents axial movement of the adjusting screw.
Abstract:
The present invention provides compounds useful, for example, for modulating insulin levels in a subject and that have the general formula Q-L1-P-L2-M-X-L3-A wherein the definitions of the variables Q, L1, P, L2, M, X, L3 and A are provided herein. The present invention also provides compositions and methods for use of the compounds, for instance, for treatment of type II diabetes.
Abstract:
A stamping die (20) includes a base set (21), a punch (241, 242, 243, 244, 245) detachably assembled on the base set, and a stripper plate (23) disposed on top of the base set. The stripper plate defines a through hole (231) through which the punch passes, and at least one elastic member (28) is disposed between the base set and the stripper plate. The stamping die can punch different shaped holes by means of changing the punch.
Abstract:
A holding fixture includes a first part, a securing member and a second part. The first part includes a first end face and a sleeve extending from the first end face, the sleeve defines a plurality of radial through holes each receiving a ball therein, and each ball has a diameter larger than the wall thickness of the sleeve therein. The securing member located around the sleeve includes a plurality of protrusions configured on an inner wall thereof, with every two neighboring protrusions defining a notch therebetween. The second part includes a body and a tail fixed on the body, with seating thereof in the sleeve enabled by an annular groove in the periphery thereof. The protrusions guide the balls into the annular groove to secure the second part on the first part.
Abstract:
The present invention provides compounds useful, for example, for modulating insulin levels in a subject and that have the general formula Q-L1-P-L2-M-X-L3-A wherein the definitions of the variables Q, L1, P, L2, M, X, L3 and A are provided herein. The present invention also provides compositions and methods for use of the compounds, for instance, for treatment of type II diabetes.
Abstract:
A scheme is provided for realizing Mobile Number Portability (MNP) by utilizing a signaling flow of prior mobile network standards such that no modification to the main apparatuses, such as VMSC, GMSC, and HLR, and the like, of the prior networks is required; only a NPDB+ apparatus is required and added, that is, a combination of NPDB and NPHLR. A user of Number portability from an original or home network to a second or other network will be a user of Number Portability out (NP out) among the users of the second network. The number section of the user belongs in the network, and it is able to assign a virtual roaming number to identify the situation of Number Portability (NP) of the user. A user of Number Portability from the second network to the home network is a user of Number Portability in (NP in) among the users of the home network. The NPDB+ apparatus is newly built to store the data of MNP mobile users who enter the home network and to accomplish the associated functions without any modification to the structure of the network. The distribution technology is used for storing the data of the NPDB+. The database is of high reliability such that the circuitous voice circuits do not existed, and the metering between the networks is easy. The newly added apparatus NPDB+ is superimposed on the prior networks, when there are less users during an early period, and only small amount of construction is required. The expansion of the capacity of the networks can be completed by adding portions of an apparatus based on the development condition of MNP services. The expansiveness of the networks is excellent, particularly, it is suitable for the mobile operating agents who have very large scale prior networks.
Abstract:
The present invention provides the use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives and compositions in the treatment of insulin resistance, Type 2 diabetes and hyperlipidemia.
Abstract:
The present invention provides the use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives and compositions in the treatment of insulin resistance, Type 2 diabetes, hyperlipidemia and hyperuricemia. It further provides (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives that are useful for the treatment of insulin resistance, Type 2 diabetes, hyperlipidemia and hyperuricemia.